50 likes | 50 Views
Pathophysiology: Cannabinoids, Emerging Evidence in Use and Abuse (Pharmacology CME) is organized by EB Medicine and will be held from Aug 01, 2018 - Aug 01, 2021.
E N D
Home / Online CME / Journal CME / Cannabinoids: Emerging Evidence in Use and Abuse (Pharmacology CME) (Aug 01, 2018 - Aug 01, 2021) Cannabinoids: Emerging Evidence in Use and Abuse (Pharmacology CME) CME : 4 Save Start Date : Aug 01, 2018 End Date : Aug 01, 2021 Organized by : EB Medicine Specialties : Clinical Pharmacology Fee : Starting From Free Interested Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Overview Topic Credit Info Speaker Contact us Conference Summary Cannabinoids: Emerging Evidence in Use and Abuse (Pharmacology CME) is organized by EB Medicine. Date of Original Release: August 1, 2018 Date of most recent review: July 10, 2018 Termination date: August 01, 2021 CME Expiration Date: August 31, 2021 Target Audience: This enduring material is designed for emergency medicine physicians, physician assistants, nurse practitioners, and residents. CME Credits: 4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits. Description: As the use of cannabinoids increases, so have ED presentations of patients with acute intoxication and cannabinoid hyperemesis syndrome. This issue reviews the latest evidence on recognizing and managing patients with emergent conditions related to cannabinoid use, including: • An overview of the pathophysiology of cannabinoids. • Current evidence on the common and uncommon clinical ?ndings associated with cannabinoid use: neurologic, psychiatric, cardiovascular, renal, metabolic, oral, and ophthalmologic. • How synthetic cannabinoids can be similar to - and different from - natural and "medical" cannabis products. • How to determine when laboratory testing is indicated, and when it is not. • A look at the current evidence on cannabinoid hyperemesis syndrome, including some emerging management strategies for this commonly misdiagnosed condition. • The latest information on the legal and FDA approval status of cannabinoid drugs. Objectives: Upon competion of this article, you should be able to: • Describe common presentations of acute intoxication due to natural and synthetic cannabinoids. Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
• List the symptoms and physical examination ?ndings for cannabinoid hyperemesis syndrome. • Identify current treatment practices in cannabinoid hyperemesis syndrome. Topic ✔Cannabis Cannabis Credit Info CME : 4 Author (s) 1 Author(s) Contact Us Toll free Number 1(800) 826-2059 Email support@eMedEvents.com Chat Assistant Live Chat Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Add Review Browse CME / CE Conferences by Specialty View All Cardiology Clinical Pharmacology Dentistry Dermatology Emergency Medicine Endocrinology Endocrinology, Metabolism and Diabetes Gastroenterology Haematology Healthcare Management Infectious Disease Medical Education Medicine Neurology Nursing Nutrition Obstetrics and Gynecology Oncology Ophthalmology Orthopedics Pain Management Pediatrics Pharmacy and Medicine Primary Care Psychiatry Psychology Pulmonary Medicine Radiology Rheumatology Surgery For Physicians Logistics Medical Resources Quick Links For Organizers Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW
Pharma & Medical Devices For Speakers eMedEvents ☰ Follow Us On Download Terms & Conditions | Security | Cookies Create PDF in your applications with the Pdfcrowd HTML to PDF API PDFCROW